Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2017

Feb 23, 2017

32566_dirs_2017-02-23_ed40b294-45db-4d4c-b7a7-f1c60fafe166.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2017-02-22

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-22 Common Stock P 2000 $18.8065 Acquired 38524 Direct
2017-02-23 Common Stock P 3600 $18.58 Acquired 42124 Direct
2017-02-23 Common Stock P 400 $18.573 Acquired 42524 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 300 Indirect